ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658356 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658356; 2) Community: the network communities that were significantly associated with the response to NSC 658356; 3) Molecule: the relationships between components within communities and NSC 658356; 4) MDR: the compounds that were significantly associated with the NSC 658356.

NSC Compound Enrichment Correlation
NSC 13151 Null 0.0352383000003056 0.18311309
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0352383000003056 0.33601904
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0352383000003056 0.1838384
NSC 244404 Null 0.0352383000003056 0.28679698
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0352383000003056 0.089428859
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0352383000003056 0.55122113
NSC 303861 L-Cysteine analog 0.0352383000003056 0.42451085
NSC 328410 Camptothecin Derivative 0.0352383000003056 0.36276633
NSC 33570 Null 0.0352383000003056 0.20474843
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0352383000003056 0.27894171
Total:133  Current:95    [First] [Prev] [Next] [Last]